Life Spine Announces Full Commercial Launch of PROLIFT® Lordotic Expandable Interbody Solution

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

Mariusz Knap, Vice President of Marketing noted, “We are excited to offer PROLIFT Lordotic with the OSSEO-LOC subtractive process, as it deepens Life Spine’s commitment to providing surgeons access to our highly differentiated, minimally invasive spinal solutions.

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders today announced the full commercial launch of PROLIFT Lordotic expandable interbody solution with OSSEO-LOC™ technology.

PROLIFT Lordotic allows for in-situ disc height restoration, for minimally invasive PLIF, TLIF and oblique approaches. PROLIFT Lordotic, which incorporates the proprietary surface technology OSSEO-LOC, provides the surgeon the ability to restore normal spinal pelvic parameters with the multiple lordotic options, while continuing to build upon the patented expandable technologies at Life Spine.

OSSEO-LOC, Life Spine’s proprietary surface treatment, creates a geometric surface architecture which offers the clinical advantage of providing an osteoclastic environment, documented for the recruitment of bone building cells (osteoblasts) on titanium implants to assist with healing and solid fusions.

Mariusz Knap, Vice President of Marketing noted, “We are excited to offer PROLIFT Lordotic with the OSSEO-LOC subtractive process, as it deepens Life Spine’s commitment to providing surgeons access to our highly differentiated, minimally invasive spinal solutions. Addressing a variety of pathologies, Life Spine’s procedural based solutions increase the value of care by delivering both the ability to correct spinal alignment, an improved patient experiences. Life Spine continues to develop technologies that centers on achieving restoration of spinal alignment, which has been proven to be a significant driver to successful, long-term surgical outcomes. This will be a driving force as we continue to expand the Life Spine armamentarium of surgical solutions, and partner with surgeons to help them deliver superior surgical outcomes.”

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.